BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1057 related articles for article (PubMed ID: 21199526)

  • 1. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
    Kew MC
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():144-52. PubMed ID: 21199526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis.
    Huo TI; Wang XW; Forgues M; Wu CG; Spillare EA; Giannini C; Brechot C; Harris CC
    Oncogene; 2001 Jun; 20(28):3620-8. PubMed ID: 11439325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis.
    Zhu R; Mok MT; Kang W; Lau SS; Yip WK; Chen Y; Lai PB; Wong VW; To KF; Sung JJ; Cheng AS; Chan HL
    J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
    Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
    Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma.
    Kim DG
    Methods Mol Biol; 2006; 317():141-55. PubMed ID: 16264227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
    Park IY; Sohn BH; Yu E; Suh DJ; Chung YH; Lee JH; Surzycki SJ; Lee YI
    Gastroenterology; 2007 Apr; 132(4):1476-94. PubMed ID: 17408664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis.
    Ma NF; Lau SH; Hu L; Xie D; Wu J; Yang J; Wang Y; Wu MC; Fung J; Bai X; Tzang CH; Fu L; Yang M; Su YA; Guan XY
    Clin Cancer Res; 2008 Aug; 14(16):5061-8. PubMed ID: 18698024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues.
    Tu H; Bonura C; Giannini C; Mouly H; Soussan P; Kew M; Paterlini-Bréchot P; Bréchot C; Kremsdorf D
    Cancer Res; 2001 Nov; 61(21):7803-10. PubMed ID: 11691796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx.
    Sirma H; Giannini C; Poussin K; Paterlini P; Kremsdorf D; Bréchot C
    Oncogene; 1999 Aug; 18(34):4848-59. PubMed ID: 10490818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular functions and biological roles of hepatitis B virus x protein.
    Tang H; Oishi N; Kaneko S; Murakami S
    Cancer Sci; 2006 Oct; 97(10):977-83. PubMed ID: 16984372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene expression profile in response to hepatitis B virus X gene by using an adenoviral vector].
    Joo HY; Han KH; Ryu WS
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):371-80. PubMed ID: 12506241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus-induced hepatocellular carcinoma.
    Xu C; Zhou W; Wang Y; Qiao L
    Cancer Lett; 2014 Apr; 345(2):216-22. PubMed ID: 23981576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The expression of hepatitis B virus X protein and cyclooxygenase-2 in hepatitis B virus-related hepatocellular carcinoma: correlation with microangiogenesis and metastasis, and what is the possible mechanism].
    Liu KG; Shao XL; Xie HH; Xu L; Zhao H; Guo ZH; Li L; Liu J
    Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):831-6. PubMed ID: 21138631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene.
    Wang XW; Gibson MK; Vermeulen W; Yeh H; Forrester K; Stürzbecher HW; Hoeijmakers JH; Harris CC
    Cancer Res; 1995 Dec; 55(24):6012-6. PubMed ID: 8521383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus X protein overcomes the growth-inhibitory potential of retinoic acid by downregulating retinoic acid receptor-beta2 expression via DNA methylation.
    Jung JK; Park SH; Jang KL
    J Gen Virol; 2010 Feb; 91(Pt 2):493-500. PubMed ID: 19828754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive gene expression profiles associated with Hepatitis B virus x protein.
    Wu CG; Salvay DM; Forgues M; Valerie K; Farnsworth J; Markin RS; Wang XW
    Oncogene; 2001 Jun; 20(28):3674-82. PubMed ID: 11439330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knock-down of hepatitis B virus X protein reduces the tumorigenicity of hepatocellular carcinoma cells.
    Chan DW; Ng IO
    J Pathol; 2006 Feb; 208(3):372-80. PubMed ID: 16353167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
    Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells.
    Park EH; Koh SS; Srisuttee R; Cho IR; Min HJ; Jhun BH; Lee YS; Jang KL; Kim CH; Johnston RN; Chung YH
    Cancer Gene Ther; 2009 May; 16(5):453-61. PubMed ID: 19096445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.